PIRS

Pieris Pharmaceuticals Stock Price

3.345
-0.025 (-0.74%)
Upgrade to Real-Time
Regular Market
3.345

Low
1.70

52 Week Range

High
5.09

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Pieris Pharmaceuticals Inc PIRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.025 -0.74% 3.345 12:16:42
Open Price Low Price High Price Close Price Prev Close
3.38 3.31 3.435 3.37
Bid Price Ask Price Spread News
3.34 3.35 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,661 686,492 $ 3.37 $ 2,312,033 - 1.70 - 5.09
Last Trade Time Type Quantity Stock Price Currency
12:17:21 42 $ 3.34 USD

Period:

Draw Mode:

Pieris Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 195.02M 58.30M 58.26M $ 29.32M $ -24.39M -0.68 -5.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 285.00k 0.20%

more financials information »

Pieris Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PIRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.413.7813.313.522,408,235-0.065-1.91%
1 Month3.93654.073.313.632,067,747-0.5915-15.03%
3 Months2.165.091.703.6811,818,7001.1954.86%
6 Months2.855.091.703.625,751,2310.49517.37%
1 Year2.955.091.703.563,030,2150.39513.39%
3 Years5.906.201.603.621,335,792-2.56-43.31%
5 Years1.719.751.303.931,014,7271.6495.61%

Pieris Pharmaceuticals Description

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States.


Your Recent History
NASDAQ
PIRS
Pieris Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.